Related Experiment Video
Updated: Apr 16, 2026

14:18
A Strategy for Sensitive, Large Scale Quantitative Metabolomics
Published on: May 27, 2014
21.9K
A weighted relative difference accumulation algorithm for dynamic metabolomics data: long-term elevated bile acids
Weijian Zhang1, Lina Zhou2, Peiyuan Yin2
1School of Computer Science &Technology, Dalian University of Technology, Dalian, China.
Scientific Reports
|March 12, 2015
Summary
Dynamic metabolomics reveals long-term elevated serum bile acids as key risk factors in hepatocellular carcinoma (HCC) development. This study introduces a novel weighted method for analyzing time-series data, enhancing disease biomarker discovery.
Area of Science:
- Biochemistry
- Systems Biology
- Oncology
Background:
- Dynamic metabolomics offers insights into metabolic changes during disease progression.
- Analyzing time-series metabolomics data is crucial for understanding biological processes.
- Existing methods often analyze isolated time points, missing temporal dynamics.
Purpose of the Study:
- To develop and apply a novel weighted method for analyzing dynamic metabolomics data.
- To identify metabolic risk factors associated with hepatocellular carcinoma (HCC) development.
- To systematically analyze temporal metabolic trajectories in disease progression.
Main Methods:
- A weighted method based on means and variations across time points was developed.
- The method was applied to retrospective rat model data and prospective HCC data.
- Permutation testing for noise filtering and false discovery rate (FDR) for feature selection were employed.
Main Results:
- Long-term elevated serum bile acids were identified as significant risk factors for HCC.
- The proposed weighted method effectively extracts temporal information from metabolomics data.
- Key metabolic features associated with HCC development were systematically identified.
Conclusions:
- Dynamic metabolomics, analyzed with a time-series weighted method, can reveal critical disease risk factors.
- Elevated serum bile acids represent a potential early warning biomarker for hepatocellular carcinoma.
- This approach enhances the understanding of metabolic contributions to cancer development.

